Alembic Pharmaceuticals was hit with a patent infringement lawsuit on Dec. 19 in New York Eastern District Court over its planned generic version of the glaucoma treatment LUMIGAN®. The action, ...

Alembic Pharmaceuticals was sued for patent infringement on Dec. 19 in New York Eastern District Court for seeking to market a generic version of glaucoma treatment Lumigan. The action, brought by ...

In a pivotal move for investors, Peter Skibitski of Alembic Global raised his rating on Northrop Grumman Corporation (NOC) to “Overweight” on December 15, 2025. This assessment signals strong ...

Alembic Pharmaceuticals Ltd has received approval from the USFDA for its generic ophthalmic suspension, used to treat eye infections. The approval includes Competitive Generic Therapy (CGT) ...

International consultancy Accenture announced last week that it had invested in AI startup Alembic, kickstarting a partnership that will leverage the technology to better measure the effectiveness of ...

Causal artificial intelligence startup Alembic Technologies Inc. said today it has raised $145 million in a Series B growth round that increases its valuation almost 16-fold. It’s using a big chunk of ...

Alembic, a startup that offers AI-powered data analytics for marketers, said it has raised $145 million in a fundraising round that values the company at $645 million. Alembic’s software is designed ...

Alembic Technologies has raised $145 million in Series B and growth funding at a valuation 15 times higher than its previous round, betting that the next competitive advantage in artificial ...

Oct 31 (Reuters) - Indian drugmaker Alembic Pharmaceuticals (ALEM.NS), opens new tab posted a 20.4% rise in second-quarter profit on Tuesday, aided by strong demand for its generic drugs as well as ...

What if the programming language you rely on most is on the brink of a transformation? For millions of developers worldwide, Python is not just a tool, it’s a cornerstone of their craft, powering ...